V
Vivo Bio Tech Ltd
BSE:511509
Vivo Bio Tech Ltd
BSE:511509
Price:
28.32
INR
-0.46%
Market Closed
Market Cap:
₹628.4m
Balance Sheet
Balance Sheet Decomposition
Vivo Bio Tech Ltd
Vivo Bio Tech Ltd
Balance Sheet Decomposition is not available for
Vivo Bio Tech Ltd
Vivo Bio Tech Ltd
Balance Sheet
Vivo Bio Tech Ltd
Vivo Bio Tech Ltd
Currency: INR
| Mar-2012 | Mar-2013 | Mar-2014 | Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||
| Cash & Cash Equivalents |
25
|
103
|
112
|
106
|
119
|
12
|
42
|
6
|
10
|
12
|
17
|
14
|
14
|
13
|
|
| Cash Equivalents |
25
|
103
|
112
|
106
|
119
|
12
|
42
|
6
|
10
|
12
|
17
|
14
|
14
|
13
|
|
| Total Receivables |
72
|
70
|
74
|
102
|
86
|
165
|
156
|
155
|
147
|
120
|
136
|
192
|
360
|
321
|
|
| Accounts Receivables |
53
|
40
|
43
|
43
|
38
|
77
|
118
|
84
|
105
|
73
|
120
|
124
|
118
|
113
|
|
| Other Receivables |
19
|
30
|
31
|
59
|
48
|
88
|
38
|
71
|
43
|
48
|
16
|
68
|
242
|
209
|
|
| Inventory |
0
|
0
|
3
|
0
|
0
|
0
|
76
|
82
|
106
|
133
|
98
|
80
|
88
|
78
|
|
| Other Current Assets |
4
|
6
|
5
|
8
|
16
|
19
|
5
|
5
|
6
|
6
|
9
|
32
|
11
|
8
|
|
| Total Current Assets |
101
|
179
|
194
|
216
|
220
|
196
|
279
|
249
|
269
|
271
|
260
|
318
|
472
|
419
|
|
| PP&E Net |
399
|
142
|
149
|
149
|
172
|
260
|
253
|
249
|
288
|
410
|
824
|
800
|
815
|
772
|
|
| Intangible Assets |
41
|
65
|
57
|
49
|
64
|
55
|
64
|
52
|
64
|
113
|
136
|
108
|
81
|
239
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
16
|
1
|
4
|
5
|
3
|
2
|
|
| Total Assets |
541
N/A
|
387
-29%
|
400
+4%
|
414
+3%
|
457
+10%
|
511
+12%
|
595
+16%
|
551
-7%
|
637
+16%
|
795
+25%
|
1 225
+54%
|
1 230
+0%
|
1 371
+11%
|
1 432
+4%
|
|
| Liabilities | |||||||||||||||
| Accounts Payable |
93
|
87
|
86
|
69
|
87
|
54
|
80
|
39
|
39
|
14
|
23
|
9
|
11
|
10
|
|
| Short-Term Debt |
21
|
0
|
31
|
30
|
0
|
0
|
0
|
0
|
0
|
119
|
0
|
116
|
227
|
114
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
28
|
61
|
112
|
128
|
147
|
44
|
174
|
77
|
86
|
77
|
|
| Other Current Liabilities |
161
|
169
|
148
|
184
|
207
|
51
|
62
|
21
|
20
|
41
|
47
|
47
|
56
|
78
|
|
| Total Current Liabilities |
276
|
256
|
264
|
283
|
322
|
166
|
254
|
188
|
206
|
218
|
244
|
250
|
379
|
278
|
|
| Long-Term Debt |
208
|
36
|
36
|
27
|
23
|
209
|
139
|
89
|
97
|
146
|
501
|
431
|
418
|
349
|
|
| Deferred Income Tax |
8
|
12
|
14
|
11
|
8
|
8
|
6
|
2
|
0
|
0
|
15
|
25
|
23
|
18
|
|
| Other Liabilities |
1
|
1
|
1
|
2
|
2
|
3
|
3
|
4
|
4
|
5
|
6
|
6
|
7
|
8
|
|
| Total Liabilities |
492
N/A
|
304
-38%
|
315
+4%
|
323
+2%
|
356
+10%
|
386
+8%
|
402
+4%
|
278
-31%
|
307
+10%
|
370
+21%
|
765
+107%
|
712
-7%
|
827
+16%
|
653
-21%
|
|
| Equity | |||||||||||||||
| Common Stock |
94
|
94
|
94
|
94
|
94
|
94
|
99
|
124
|
129
|
134
|
143
|
149
|
149
|
172
|
|
| Retained Earnings |
44
|
11
|
8
|
2
|
7
|
32
|
95
|
149
|
201
|
291
|
317
|
370
|
395
|
607
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
49
N/A
|
82
+67%
|
85
+3%
|
92
+8%
|
101
+10%
|
126
+25%
|
193
+54%
|
273
+41%
|
330
+21%
|
425
+29%
|
459
+8%
|
519
+13%
|
544
+5%
|
779
+43%
|
|
| Total Liabilities & Equity |
541
N/A
|
387
-29%
|
400
+4%
|
414
+3%
|
457
+10%
|
511
+12%
|
595
+16%
|
551
-7%
|
637
+16%
|
795
+25%
|
1 225
+54%
|
1 230
+0%
|
1 371
+11%
|
1 432
+4%
|
|
| Shares Outstanding | |||||||||||||||
| Common Shares Outstanding |
9
|
9
|
9
|
9
|
9
|
9
|
9
|
12
|
13
|
13
|
14
|
15
|
15
|
17
|
|
Switch to:
Switch to:
See Also
Discover More
